Trial intelligence / Profile preview

Longqing tablets vs levofloxacin in acute uncomplicated lower urinary tract infection

ChiCTR2400084823Phase 4Recruiting

Sponsor
Tongji Hospital
Start
May 2024
Countries
1
01

Overview

Phase 4, randomised trial of Longqing in bacterial cystitis (3 arms), sponsored by Tongji Hospital. Primary endpoint: Comprehensive curative effect cure rate. Started May 2024; status: recruiting.

02

Drugs

Longqing
03

Conditions

bacterial cystitis

Beyond the preview

Go deeper on ChiCTR2400084823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400084823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call